Andrew Kay

Andrew joined LifeSci Consulting as an Analyst in 2026. He earned his B.A. in Chemistry with a minor in Economics from Emory University, graduating Phi Beta Kappa and Omicron Delta Epsilon, and brings a combination of laboratory and industry experience.

At BioMarin Pharmaceutical, he interned on the Network Strategy team, where he supported integration management for the company’s acquisition of Inozyme Pharma and developed supply chain visualizations of the company’s full commercial network to identify bottlenecks and enable optimization for executive decision-making.

At Emory’s Lowance Center for Human Immunology, he worked in a laboratory researching a pathway believed to contribute to autoreactivity in systemic lupus erythematosus, collecting data on a large panel of monoclonal antibodies at different development stages to identify patterns between gene expression and B cell autoreactivity. On campus, he served as Director of Programming for the Emory Life Science Consulting Club, coordinating on-campus and virtual events including client meetings, casing workshops, and guest speakers.